Summary
77 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 29% a year over the last 3 years.
- Out of every 100 USD of revenue, 28 USD is left as net profit.
- It has no debt and holds $6.80B in cash.
- It earns 15 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 48.8 USD for 1 USD of yearly profit. Over the last five years it was 74.0 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 18% a year over 5 years. Over the last 3 years it grew by 17% a year. For the next fiscal year analysts expect revenue to grow by 18%. Earnings per share grew by 29% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 33 USD
- Research and development 13 USD
- Sales and administration 26 USD
- Taxes and other 2.8 USD
- Net profit 26 USD
Net profit, industry median (Medical - Instruments & Supplies) 8.1 USD
Out of every 100 USD of revenue, 26 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 40
- Hold 12
- Sell 5
Today's price within the analysts' price targets
The average target of $482.56 is 6.7% above today's price. 70% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Instruments and Accessories 60%
- Systems 25%
- Services 16%
By region
- Geographic Distribution, Domestic 68%
- Geographic Distribution, Foreign 32%
Instruments and Accessories brings in 60% of revenue.
Segments in detail